GB202015261D0 - Remaining drug dosage time identification system - Google Patents

Remaining drug dosage time identification system

Info

Publication number
GB202015261D0
GB202015261D0 GBGB2015261.7A GB202015261A GB202015261D0 GB 202015261 D0 GB202015261 D0 GB 202015261D0 GB 202015261 A GB202015261 A GB 202015261A GB 202015261 D0 GB202015261 D0 GB 202015261D0
Authority
GB
United Kingdom
Prior art keywords
identification system
drug dosage
time identification
remaining drug
dosage time
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2015261.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB202015261D0 publication Critical patent/GB202015261D0/en
Ceased legal-status Critical Current

Links

GBGB2015261.7A 2020-06-19 2020-09-28 Remaining drug dosage time identification system Ceased GB202015261D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010566855.6A CN111653335A (zh) 2020-06-19 2020-06-19 剩余药品剂量用时识别系统

Publications (1)

Publication Number Publication Date
GB202015261D0 true GB202015261D0 (en) 2020-11-11

Family

ID=72348053

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2015261.7A Ceased GB202015261D0 (en) 2020-06-19 2020-09-28 Remaining drug dosage time identification system

Country Status (2)

Country Link
CN (1) CN111653335A (zh)
GB (1) GB202015261D0 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022160197A1 (zh) * 2021-01-28 2022-08-04 深圳麦科田生物医疗技术股份有限公司 自动换药雾化装置
CN113155662A (zh) * 2021-03-30 2021-07-23 湘潭市计量测试检定所 医用压缩雾化器残留液量的检测方法
CN113694325A (zh) * 2021-08-09 2021-11-26 常州工学院 一种雾化器用智能药液杯

Also Published As

Publication number Publication date
CN111653335A (zh) 2020-09-11

Similar Documents

Publication Publication Date Title
IL304532A (en) Dose discovery and drug identification for a drug administration facility
IL273663A (en) System and methods for disinfecting a drug delivery device
IL276757A (en) Dose detection system module for drug delivery device
GB202015261D0 (en) Remaining drug dosage time identification system
GB2583865B (en) System and method for dispensing medication
IL272278A (en) Topical antiseptic for drug delivery system
ZA201905410B (en) Sterile drug dispensing system and sterile drug dispensing method
IL279127A (en) Dispensing devices for drug administration
HUE060952T2 (hu) Újszerû gyógyszer-adagolási rendszer és annak elõállítására szolgáló módszer
GB202103724D0 (en) Pharmaceuticals solution for oral dosage
GB201916947D0 (en) Dosage dispensing system
CA215994S (en) Drug delivery system
CA215997S (en) Drug delivery system
CA215995S (en) Drug delivery system
IL308261A (en) An intelligent drug administration system
ZA202105940B (en) Drug delivery system
NO20161568A1 (en) A new drug delivery system for treatment of cancer
GB202101783D0 (en) Medicine evaluation system
EP4118401A4 (en) MEDICINE DISPENSING MONITORING SYSTEM
IL275168A (en) Medicine admininstering system
IL279128A (en) Dispensing devices for drug administration
ZA202302641B (en) Transdermal drug delivery system
GB201909814D0 (en) Optimal dose pill system
GB202111785D0 (en) Medication dispensing method & system
GB201801043D0 (en) System and method for drug dosage medicament regime adherence monitoring

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)